XML 134 R103.htm IDEA: XBRL DOCUMENT v3.25.3
SEMPRA - EQUITY AND EARNINGS PER COMMON SHARE - EARNINGS PER COMMON SHARE (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Earnings attributable to common shares, basic $ 77 $ 638 $ 1,444 $ 2,152
Earnings attributable to common shares, diluted $ 77 $ 638 $ 1,444 $ 2,152
Weighted-average common shares outstanding for basic EPS (in shares) 652,948,000 633,752,000 652,538,000 633,342,000
Dilutive effect of common shares sold forward (in shares) 267,000 2,312,000 123,000 1,375,000
Dilutive effect of stock options and RSUs (in shares) 794,000 1,997,000 759,000 1,849,000
Weighted-average common shares outstanding for diluted EPS (in shares) 654,009,000 638,061,000 653,420,000 636,566,000
Earnings per share, basic (dollars per share) $ 0.12 $ 1.01 $ 2.21 $ 3.40
Earnings per share, diluted (in dollars per share) $ 0.12 $ 1.00 $ 2.21 $ 3.38
Vested RSUs included in basic WASO (in shares) 492,000 615,000 502,000 616,000
Stock options, RSAs and RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Non-qualified stock options granted (in shares)     303,614  
Performance-based RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Equity awards, granted (in shares)     628,413  
Service-based RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Equity awards, granted (in shares)     260,012  
Stock options, RSAs and RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Antidilutive securities excluded from earnings per share (in shares) 331,462 450,243 743,454 996,966